Geerdsen J P, Frølund L
Clin Endocrinol (Oxf). 1984 Nov;21(5):529-33. doi: 10.1111/j.1365-2265.1984.tb01391.x.
The incidence of postoperative recurrence of nontoxic goitre was evaluated in 175 patients. The average observation period was 8.8 years. Levothyroxine (Eltroxin) had been taken by 104 of these patients as long-term prophylaxis against goitre recurrence. Ten (9.5%) of the 104 had recurrence. The other 71 patients received no or only brief thyroxine medication postoperatively. In this group there were eight recurrences (11.3%). The difference was not significant, nor did the two groups differ significantly in regard to sex and age distribution, pathologic anatomy and observation time. Routine long-term administration of thyroxine after thyroid resection is not justified from the results of this study.
对175例非毒性甲状腺肿患者的术后复发率进行了评估。平均观察期为8.8年。其中104例患者长期服用左甲状腺素(优甲乐)以预防甲状腺肿复发。这104例中有10例(9.5%)复发。另外71例患者术后未服用或仅短期服用甲状腺素。该组中有8例复发(11.3%)。差异无统计学意义,两组在性别、年龄分布、病理解剖及观察时间方面也无显著差异。从本研究结果来看,甲状腺切除术后常规长期服用甲状腺素并无依据。